• 50% Bile Acid Content Ox Bile Powder with DMF
  • 50% Bile Acid Content Ox Bile Powder with DMF
  • 50% Bile Acid Content Ox Bile Powder with DMF
  • 50% Bile Acid Content Ox Bile Powder with DMF
  • 50% Bile Acid Content Ox Bile Powder with DMF

50% Bile Acid Content Ox Bile Powder with DMF

Certification: ISO
Storage Method: Normal
Extraction Process: Physical
Application: Food, Health Care Products, Medicine
State: Powder
Extract Source: Cow
Customization:
Gold Member Since 2023

Suppliers with verified business licenses

Trading Company
  • Overview
  • Product Description
  • Detailed Photos
  • Product Parameters
  • Company Profile
Overview

Basic Info.

Model NO.
HJ
Characteristic
Yellowish-Brown to Tawny Powder, Bitter, Hygroscop
Identification
on The Corresponding Position of Reference Chroma
Water
≤5.0%
Pulvis Fellis Suis
on The Corresponding Position of Pulvis Fellis Sui
Bile Acid Content
≥45%
Transport Package
25kg/Drum
Specification
25kg/drum
Trademark
HD
Origin
China
HS Code
3003900090
Production Capacity
10000000/Kg

Product Description

Product Description

1.1 Name
Ox bile extract. 


1.2 Packaging and labeling requirements

Package 25KG/drum
Label The label in English shall indicate the manufacturer's name, address, product name, net weight and total weight (kg), Batch No., production date, shelf life, storage condition.

 

Detailed Photos

50% Bile Acid Content Ox Bile Powder with DMF50% Bile Acid Content Ox Bile Powder with DMF

Product Parameters
 
Qualitative and quantitative characteristics

Items

Standard

Results

Characteristic
,,.
Yellowish-brown to tawny powder, bitter, hygroscopicity.

Conform

Identification
,
On the corresponding position of reference  chromatogram, should appear the same color spots

Conform

Water
≤5.0% 2.6%

Pulvis fellis suis
,
On the corresponding position of pulvis fellis suis chromatogram, shall not appear the same color spots

Conform

Particle Size
80 mesh
Conform

Bile acid content
≥45% 56.2%

Total amount of aerobe
≤1000 cfu/g
Conform

Molds and yeast count
≤100 cfu/g
Conform

Escherichia coli

Not detectable/g

Conform

Salmonella

Not detectable/10g

Conform

Staphylococcus aureus

Not detectable/g

Conform

Conclusion

It conforms to the enterprise standard.

 

Company Profile

Huadi Group is a national high-tech enterprise. It is invested and established by a group of professionals who are specialized in the R&D of the biopharmaceutical field and have rich experience in production management and operation. It is a group company that invests in the production of diversified industries such as pharmaceuticals, medical devices, food, health products, cosmetics, and biological agriculture products.

Huadi Group has a total of 8 subsidiaries: Zhejiang Huadi Pharmaceutical Group Co., Ltd., Hangzhou Huajin Pharmaceutical Co., Ltd., Zhejiang Huajun Pharmaceutical Co., Ltd., Zhejiang Huadi Pharmaceutical Group Pharmaceutical Development Co., Ltd., Hangzhou Huadi Health Technology Co., Ltd., Leizhou Huadi Biotechnology Co., Ltd., Hainan Huadi Pharmaceutical Co., Ltd., Hunan Huadi Biotechnology Co., Ltd.

Huadi Group is the vice president unit of the China Biochemical Pharmaceutical Industry Association and the vice president unit of the Zhejiang Health Industry Research Association. Its controlling subsidiary, Zhejiang Huadi Pharmaceutical Group, is the drafting unit of the GMP appendix for biochemical drugs of the National Good Manufacturing Practice for Drugs. The group has two provincial-level R&D centers, the Chief Scientist is a senior scientist and overseas returnee PhD from a fortune 500 company in the United States. The company has long hired domestic and foreign experts and scholars as technical consultants, with strong technological innovation capabilities. With nearly 30 years of R&D and industrial transformation experience in biochemical extraction products, multi-component biochemical drugs, and synthetic peptide products, the technical level is leading domestically; In 2019, the group jointly launched internationally leading biopharmaceutical cutting-edge projects with senior research teams from the United States and Zhejiang University: the preparation of medicinal proteins using plant instantaneous expression systems, and the personalized treatment of tumors - neoantigen peptide project. All of these projects have made breakthrough progress and their technical level is internationally leading.

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Gold Member Since 2023

Suppliers with verified business licenses

Trading Company
Number of Employees
39
Year of Establishment
2011-02-10